Skip to main content

Defendant Opposes Bellwether Pool Reduction in Stryker MDL

Defendant Opposes Bellwether Pool Reduction in Stryker MDL

Defendant Opposes Bellwether Pool Reduction in Stryker MDL

Introduction

The defendant involved in the Stryker LFIT V40 Femoral Head MDL submitted a brief on September 6, requesting Massachusetts federal judge to deny the plaintiffs' motion, which states to reduce the bellwether pool from 18 to 8 cases. The defendant claims that the parties have already agreed to limited discovery depositions in 18 cases and there is no good reason to alter the number of bellwethers at this stage of the MDL.

Stryker faces hundreds of product liability lawsuits linked to the complications of its LFIT hip implant. Lawsuits filed against the manufacturer have been centralized for coordinated pretrial proceedings in the U.S. District Court for the District of Massachusetts presided over by Judge Indira Talwani. The first bellwether trial has been scheduled to commence in September 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!